Medco argues that Pfizer's scheme will save money for all parties, and ensure a steady supply of the drug (Ranbaxy's regulatory struggles are bound to have caused some concern).

ECONOMIST: Drugmakers

Recently, in connection with a review of in-bound shipments of the Galvanic Spa facial unit, the U.S. Food and Drug Administration (FDA) indicated its belief that the product needed to be registered as a medical device before being imported.

FORBES: Preying on an Easy Mark